收费全文 | 50334篇 |
免费 | 4442篇 |
国内免费 | 875篇 |
耳鼻咽喉 | 250篇 |
儿科学 | 2358篇 |
妇产科学 | 817篇 |
基础医学 | 5059篇 |
口腔科学 | 994篇 |
临床医学 | 6641篇 |
内科学 | 7782篇 |
皮肤病学 | 690篇 |
神经病学 | 805篇 |
特种医学 | 811篇 |
外国民族医学 | 1篇 |
外科学 | 5731篇 |
综合类 | 7278篇 |
现状与发展 | 7篇 |
预防医学 | 9847篇 |
眼科学 | 289篇 |
药学 | 4144篇 |
41篇 | |
中国医学 | 1014篇 |
肿瘤学 | 1092篇 |
2024年 | 136篇 |
2023年 | 861篇 |
2022年 | 1648篇 |
2021年 | 2399篇 |
2020年 | 2446篇 |
2019年 | 1921篇 |
2018年 | 1857篇 |
2017年 | 1823篇 |
2016年 | 1968篇 |
2015年 | 2128篇 |
2014年 | 3480篇 |
2013年 | 3964篇 |
2012年 | 3465篇 |
2011年 | 3542篇 |
2010年 | 2510篇 |
2009年 | 2320篇 |
2008年 | 2195篇 |
2007年 | 2248篇 |
2006年 | 2153篇 |
2005年 | 1883篇 |
2004年 | 1553篇 |
2003年 | 1338篇 |
2002年 | 961篇 |
2001年 | 877篇 |
2000年 | 718篇 |
1999年 | 672篇 |
1998年 | 538篇 |
1997年 | 499篇 |
1996年 | 435篇 |
1995年 | 415篇 |
1994年 | 386篇 |
1993年 | 325篇 |
1992年 | 292篇 |
1991年 | 275篇 |
1990年 | 198篇 |
1989年 | 207篇 |
1988年 | 157篇 |
1987年 | 127篇 |
1986年 | 100篇 |
1985年 | 137篇 |
1984年 | 84篇 |
1983年 | 66篇 |
1982年 | 76篇 |
1981年 | 63篇 |
1980年 | 40篇 |
1979年 | 40篇 |
1978年 | 24篇 |
1977年 | 25篇 |
1976年 | 33篇 |
1975年 | 15篇 |
Methods: Four patients aged 21–61 years (three females, one male) had confirmed ocular complications connected with a general upper respiratory tract infection with myalgia and fever. Ophthalmological examination, including a visual acuity test, a slit-lamp exam, intraocular pressure measurements, fluorescein and indocyanine green angiography, optical coherence tomography (OCT), and diagnostic tests for influenza were performed in the patients (RT-PCR, HAI).
Results: Acute posterior multifocal placoid pigment epitheliopathy (APMPPE) was diagnosed in three patients and serous macular detachment (SME) in one. Influenza virus infection was confirmed by molecular biological methods (RT-PCR) or the hemagglutination inhibition test (HAI) in two patients. All patients were treated with systemic prednisone.
Conclusion: A coincidence between APMPPE and SME epitheliopathy and influenza virus infection was observed in different months of a given epidemic season. 相似文献
Objectives
Triazole resistance in Aspergillus spp. is emerging and complicates prophylaxis and treatment of invasive aspergillosis (IA) worldwide. New polymerase chain reaction (PCR) tests on broncho-alveolar lavage (BAL) fluid allow for detection of triazole resistance at a genetic level, which has opened up new possibilities for targeted therapy. In the absence of clinical trials, a modelling study delivers estimates of the added value of resistance detection with PCR, and which empiric therapy would be optimal when local resistance rates are known.Design
A decision-analytic modelling study was performed based on epidemiological data of IA, extended with estimated dynamics of resistance rates and treatment effectiveness. Six clinical strategies were compared that differ in use of PCR diagnostics (used vs not used) and in empiric therapeutic choice in case of unknown triazole susceptibility: voriconazole, liposomal amphotericin B (LAmB) or both. Outcome measures were proportion of correct treatment, survival and serious adverse events.Results
Implementing aspergillus PCR tests was projected to result in residual treatment-susceptibility mismatches of <5% for a triazole resistance rate up to 20% (using voriconazole). Empiric LAmB outperformed voriconazole at resistance rates >5–20%, depending on PCR use and estimated survival benefits of voriconazole over LAmB. Combination therapy of voriconazole and LAmB performed best at all resistance rates, but the advantage over the other strategies should be weighed against the expected increased number of drug-related serious adverse events. The advantage of combination therapy over LAmB monotherapy became smaller at higher triazole resistance rates.Conclusions
Introduction of current aspergillus PCR tests on BAL fluid is an effective way to increase the proportion of patients that receive targeted therapy for IA. The results indicate that close monitoring of background resistance rates and adverse drug events are important to attain the potential benefits of LAmB. The choice of strategy ultimately depends on the probability of triazole resistance, the availability of PCR and individual patient characteristics. 相似文献Methods: We reviewed medical records of patients who had a positive serological test for Toxoplasma gondii-specific IgM Ab. Their clinical data, including history, demographic characteristics, laboratory findings, clinical findings, treatment outcomes, and recurrences, were reviewed retrospectively.
Results: Of 2919 uveitis patients who underwent a serological test for suspected ocular toxoplasmosis (OT), 18 presented with positive Ig M results. All 18 patients (100.0% specificity) were clinically diagnosed with OT. None had any retinochoroidal scar at the initial visit, indicating the OT was a recent and primary infection. However, 15 patients (83.3%) had no history suspected to account for the Toxoplasma transmission.
Conclusions: The T. gondii IgM serum Ab is a specific biomarker for diagnosis of primary OT. Epidemiological studies are warranted to investigate the non-classic transmission routes of T. gondii in OT. 相似文献